SCHEMBL6299247

SCHEMBL6299247

CC(C)(C)OC(=O)N1CCN(c2cc(C(=O)O)cc3ccoc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 2/20 0.47
CKS1B P61024 2/20 0.46
SKP1 P63208 2/20 0.46
SKP2 Q13309 2/20 0.46
ABCB1 P08183 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
SMARCA2 P51531 1/20 0.43
SMARCA4 P51532 1/20 0.43
PBRM1 Q86U86 1/20 0.43
ADORA2A P29274 2/20 0.43
ADORA1 P30542 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
ACHE P22303 1/20 0.42
BACE1 P56817 1/20 0.42
KIT P10721 1/20 0.41
HDAC4 P56524 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1059051 0.85 SMARCA2 (0.49) CKS1BSKP1SKP2ABCB1ABCG2
Hydrochloric Acid SCHEMBL6793804 0.84 SMARCA2 (0.48) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL6298047 0.83 ACHE (0.44) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL1064174 0.81 MAPT (0.60) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL8043687 0.81 CKS1B (0.49) CKS1BSKP1SKP2
SCHEMBL18471022 0.78 ABCB1 (0.54) GBA1CKS1BSKP1SKP2ABCB1
SCHEMBL6299519 0.78 ACHE (0.42) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL6299522 0.77 ABCB1 (0.39) GBA1CKS1BSKP1SKP2ABCB1
SCHEMBL5988593 0.75 ALDH1A1 (0.50) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL8560546 0.75 CKS1B (0.49) GBA1CKS1BSKP1SKP2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6967201-B1 for increasing activation of the 5-HT2C receptor in mammals; treatment of depression, obesity, bulimia, premenstrual syndrome, alcoholism, tobacco abuse, panic disorder ELI LILLY AND COMPANY (US) 2005-11-22 US disclosed
EP-1204654-B1 BENZOFURYLPIPERAZINES: 5-HT2C SEROTONIN RECEPTOR AGONISTS LILLY CO ELI (US) 2003-07-23 EP disclosed
EP-1204654-A1 BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS ELI LILLY AND COMPANY (US) 2002-05-15 EP disclosed
WO-2001009111-A1 BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS ELI LILLY AND COMPANY (US) 2001-02-08 WO disclosed